Response prediction to oxaliplatin plus 5‑fluorouracil chemotherapy in patients with colorectal cancer using a four‑protein immunohistochemical modelJunjie Gu, Chunmei Bai|Oncology Letters|2019Cited by 38
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and BiomarkersYakun Wang, Lin Shen, Gongyan Chen et al.|The Oncologist|2022Cited by 15